Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA).

Full DD Report for SNNA

You must become a subscriber to view this report.


Recent News from (NASDAQ: SNNA)

Sienna Biopharmaceuticals Announces Its Topical, Non-Steroidal TrkA Inhibitor SNA-120 (0.05%) Demonstrated Significant Impact on Psoriasis in Phase 2b Study and Plans to Initiate Phase 3 Psoriasis Trials in Second Half of 2019
-- 27% of subjects achieved 75% reduction in PASI score (PASI 75) vs 13% with vehicle; 29% of subjects achieved two-grade improvement on IGA and ‘clear’ or ‘almost clear’ skin vs 13% with vehicle (statistically significant) -- Subjects achieved 58% improveme...
Source: GlobeNewswire
Date: December, 03 2018 07:05
Your Daily Pharma Scoop: ESPR Phase 3 Positive, FDA Rejects Volanesorsen, Ozempic Succeeds
Stocks in News: ESPR Esperion announces positive results from phase 3 bempedoic acid/ezetimibe combination pill study Discussion: Positive top-line results from the pivotal Phase 3 trial of Esperion’s ( ESPR ) bempedoic acid/ezetimibe combination pill study ( 1...
Source: SeekingAlpha
Date: August, 29 2018 13:18
Sienna Bio up 3% on advancement of SNA-125
Sienna Biopharmaceuticals ( SNNA +2.6% )  announces results from a first-in-human study of JAK3/TrkA inhibitor SNA-125 for the topical treatment of mild-to-moderate psoriasis. More news on: Sienna Biopharmaceuticals, Healthcare stocks news, Stocks on the move, Read more .....
Source: SeekingAlpha
Date: August, 27 2018 10:02
Sienna Biopharmaceuticals Announces Results from First-in-Human Study of SNA-125 in Psoriasis and Continued Progression to Phase 2
-- Phase 1/2 study data of SNA-125 in atopic dermatitis on track to be released in fourth quarter of 2018 -- SNA-125 Phase 2 studies expected to begin in second half of 2019 WESTLAKE VILLAGE, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA...
Source: GlobeNewswire
Date: August, 27 2018 09:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1416.1416.4716.61515.90440,466

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-149,58749,29219.4494Cover
2018-12-138,39427,62330.3877Cover
2018-12-127,82925,23431.0256Cover
2018-12-118,74917,34250.4498Short
2018-12-1019,42564,04430.3307Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SNNA.


About Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA)

Logo for Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: SNNA)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 27 2018
      Prospectus filed under Rule 424(b)(5)
      Filing Type: 424B5Filing Source: edgar
      Filing Date: August, 23 2018
      Correspondence from the Filer to the SEC
      Filing Type: CORRESPFiling Source: edgar
      Filing Date: August, 10 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 09 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: August, 09 2018
      Correspondence from the SEC to the Filer
      Filing Type: UPLOADFiling Source: edgar
      Filing Date: August, 09 2018
      Simplified registration form
      Filing Type: S-3Filing Source: edgar
      Filing Date: August, 03 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 02 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: July, 30 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: July, 24 2018

       

       


      Daily Technical Chart for (NASDAQ: SNNA)

      Daily Technical Chart for (NASDAQ: SNNA)


      Stay tuned for daily updates and more on (NASDAQ: SNNA)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: SNNA)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SNNA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of SNNA and does not buy, sell, or trade any shares of SNNA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/